Lower limb somatosensory discrimination is impaired in people with Parkinson's disease: novel assessment and associations with balance, gait and falls by Gorst, T et al.
1 
 
Title: Lower limb somatosensory discrimination is impaired in people with Parkinson’s disease: 1 
novel assessment and associations with balance, gait and falls.   2 
 3 
Authors: Terry Gorst PhD1, Jonathan Marsden PhD1; Jenny Freeman PhD1 4 
 5 
Corresponding Author: Dr Terry Gorst, School of Health Professions, PAHC, University of 6 
Plymouth, Derriford Road, Plymouth PL6 8BH; terry.gorst@plymouth.ac.uk; Tel: 01752 587599 7 
 8 
Word Count: Main text: 3556; Abstract: 250 9 
 10 
Running title: Somatosensory discrimination in Parkinson’s disease 11 
 12 
Key words: Parkinson’s disease, somatosensory, outcome measure, lower limb, mobility 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
2 
 
Abstract 27 
Background: People with Parkinson’s disease (PD) often have compromised walking and balance. 28 
This may be due to impaired lower limb tactile and proprioceptive sensation. Existing clinical 29 
measures may not be sufficiently sensitive to uncover these sensory impairments. 30 
Objective: Determine whether novel measures of lower limb somatosensory discrimination are 31 
psychometrically robust and associated with mobility outcomes in people with PD.   32 
Methods. Lower limb somatosensation was assessed on two occasions, 3-7 days apart, using three 33 
novel tests: gradient discrimination, roughness discrimination, and step height discrimination. Static 34 
and dynamic balance (Brief Balance Evaluations Systems Test), falls incidence, falls confidence 35 
(Falls Efficacy Scale), gait (speed and step length) were also obtained.  Participants were twenty-36 
seven people with PD and twenty-seven healthy controls (HC). 37 
Results: Novel tests showed good-excellent intra-rater reliability (ICC=0.72-0.92). Significantly 38 
higher gradient and step height discrimination thresholds (p<0.01) were demonstrated in PD 39 
compared to HC, indicating worse position sense at the ankle, knee and hip. Significant correlations 40 
were identified between gradient discrimination and falls incidence (r=0.55),  falls confidence 41 
(r=0.44), balance (r=0.63), but not gait (r=0.21). Step height discrimination was significantly 42 
correlated with balance (r=0.54). Foot roughness discrimination was not significantly different 43 
between people with PD and HC and was not significantly correlated with mobility measures 44 
(p>0.05).  45 
Conclusion:  These novel tests are psychometrically robust and identify impaired lower limb position 46 
sense which were associated with balance and falls in this sample of PD. Interventions targeting 47 
somatosensory processing in PD may improve aspects of balance and reduce falls risk. Further 48 
research is warranted. 49 
 50 
 51 
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Introduction 52 
Parkinson’s disease (PD) is the second-most common neurodegenerative disease after 53 
dementia.1  It is a progressive neurological condition characterised by both motor and non-motor 54 
symptoms with  many clinical symptoms related to difficulties with movement. Such difficulties often 55 
lead to postural instability, reductions in walking ability and impaired balance which negatively 56 
impact participation in activities of daily living, quality of life and falls.2,3  57 
The view that movement difficulties in people with Parkinson’s disease (PD) are attributable 58 
purely to motor deficits has been challenged in recent years by evidence of impaired processing and 59 
integration of somatosensory information4. Tactile and proprioceptive sense, referred to as 60 
somatosensation, arise from sensory receptors in skin, joints, tendons, and muscles providing 61 
feedback of an individual’s body position, body and limb motion, and interaction with the 62 
environment.5  Studies have shown people with PD to have deficits in somatosensory processing such 63 
as elevated thresholds to spatial and temporal stimuli,4 diminished proprioceptive and position sense 64 
awareness,6,7  and impaired haptic sensation.8  Moreover, when visual feedback cannot be used, 65 
people with PD lack precision in their stepping,9 show greater errors in obstacle clearance,10 and have 66 
greater difficulty controlling postural orientation on the basis of available somatosensory and 67 
vestibular information compared to healthy controls11. Unsurprisingly, deficits in lower limb 68 
proprioception are significantly associated with falls incidence in people with PD.7 It is feasible to 69 
posit that sensory deficits may contribute to many of the movement and balance difficulties which are 70 
the hallmark of PD. Accurately identifying and quantifying the severity of lower limb somatosensory 71 
abnormalities and, crucially, how they are associated with activity and participation limitations 72 
represents an important goal to inform rehabilitation interventions. 73 
Several measures of somatosensory function have been evaluated and reviewed12 in 74 
neurological populations, with the Erasmus MC modified Nottingham Sensory Assessment 75 
(EmNSA)13, and the sensory scale of the Fugl-Meyer Assessment14 suggested to provide the best 76 
balance of clinical utility and psychometric robustness12. Those measures, however, have been widely 77 
criticised for largely assessing the detection of stimuli - the lowest level of sensory processing15, not 78 
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providing functionally meaningful somatosensory data, and being insufficient for uncovering the 79 
complexities of somatosensory perception4,16,17. Furthermore, they have not been evaluated in people 80 
with PD.  A recent review of proprioception assessment methods18 highlights a concerning paradox: 81 
measures which possess clinical utility lack accuracy, whilst those which possess accuracy lack 82 
clinical utility. More complex tests of tactile sensation and proprioceptive function such as matching 83 
one or more standardised sensations to another, integrating sensation with motor output or 84 
distinguishing the temporal or spatial qualities of two stimuli have been shown to uncover 85 
somatosensory dysfunction in Parkinson’s, yet are largely limited to the laboratory setting.4,6 In 86 
response to the perceived shortcomings of existing clinical measures, we developed three novel and 87 
functionally oriented tests of somatosensory discrimination: the Foot Roughness Discrimination Test 88 
(FoRDT™), the Step height Discrimination Test (StepDT™) and the Gradient Discrimination Test 89 
(GradDT™). These functionally oriented tests have been described and evaluated previously in a 90 
stroke population19,20  showing superior psychometric properties to the clinically feasible and 91 
psychometrically robust sensory measure the Erasmus MC modified version of the Nottingham 92 
Sensory Assessment (EmNSA).13  To date, however, our novel tests have not been evaluated in people 93 
with PD.  94 
The aim of this study was to evaluate the psychometric properties of these novel somatosensory 95 
measures in people with PD, and report on their associations with clinical measures of gait, balance 96 
and falls. Specific objectives were to evaluate intra-rater reliability of the novel measures and 97 
convergent and known-group validity. Further, we wished to explore the association between our 98 
novel measures with functional measures of gait, balance and falls in people with PD.   99 
Method 100 
Participants 101 
We recruited a convenience sample of 27 people with PD and 27 age matched healthy 102 
controls.  People with PD were identified through local branches of Parkinson’s UK (a UK charity) 103 
and healthy age matched controls were recruited through the University of the 3rd Age (a UK 104 
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volunteer-led organisation providing educational and leisure opportunities to retired/semi-retired 105 
individuals).  Inclusion criteria were: ability to provide informed consent, walk 10 meters 106 
unsupervised (with or without a walking aid), have no have significant cognitive impairment (≥24/30 107 
Mini Mental State Examination, MMSE)21 or comorbidities known to affect somatosensation (e.g. 108 
diabetic neuropathy). Age matched control participants were included providing they had no 109 
pathological conditions known to affect balance, mobility or sensation. Sample size calculations22 110 
indicated a sample size ≥ 27 per group was sufficient for: a 95% CI of 0.25 and a planned ICC of 0.8 111 
(α=0.05); detecting a correlation coefficient of 0.29 (power=0.85, α=0.05); and effect size of 0.79 112 
(power=0.85, α=0.05).   113 
Procedures 114 
Ethical approval was obtained from the University of Plymouth, Faculty of Health and 115 
Human Sciences Research Ethics Committee (ref: 17/18-86). People with PD (n=27) were tested with 116 
the novel sensory measures on two occasions, between 3-7 days apart at the same time of day and in 117 
their self-reported ON state; that is the state in which they felt they were optimally responsive to their 118 
medication.  The first author was the rater on test session 1 and test session 2. Control participants 119 
(n=27) were tested with the novel measures on just one occasion.  120 
Participant demographic characteristics (age, gender) and in the case of people with PD, time 121 
since diagnosis, upper and lower limb motor function (Movement Disorder Society - Unified 122 
Parkinson’s Disease Rating Scale motor score Part III (MDS –UPDRS III)23 was collected. Alongside 123 
the somatosensory tests a range of different health constructs were measured, described below. 124 
Outcome measures: 125 
The EmNSA13 was used to determine convergent validity of our novel tests. It is considered to 126 
be a psychometrically robust and clinically feasible assessment tool12 involving the assessment of 127 
exteroceptive sensation (light touch, pressure touch, and pin-prick), higher cortical discriminatory 128 
sensation (sharp-blunt) and proprioception (movement detection and discrimination).   129 
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The Gradient Discrimination Test (GradDT™) evaluates sensory-perceptual ability to 130 
discriminate underfoot surface gradient or slope during standing.  It has been described previously and 131 
shown to be reliable and valid in a stroke population.20   It utilises a two alternative forced choice 132 
paradigm (2AFC),24  in which two differing sloping platforms, a base and a comparator, are mentally 133 
compared (discriminated). The test procedure involves participants standing on a series of adjustable 134 
sloping platforms until a discrimination threshold is reached (i.e. the point at which the participant 135 
cannot discriminate between two different slopes). This provides a discrimination threshold in degrees 136 
(°).  The test takes 7-10 minutes to complete.  137 
The Step height Discrimination Test (StepDT™) utilises the 2AFC approach as detailed 138 
above and has been described and psychometrically evaluated previously in stroke.20  This test 139 
assesses an individual’s ability to discriminate the height of a step, through lower limb position sense, 140 
without visual feedback. The test involves the passive placement of the test limb onto a series of 141 
adjustable steps. The 2AFC test procedure involves increasingly difficult trials until the point at which 142 
the individual cannot consistently discriminate which of the two presented steps is highest.  This 143 
provides a discrimination threshold in centimetres (cm).  144 
The Foot Roughness Discrimination Test (FoRDT™), described and evaluated previously,19  145 
assesses haptic tactile sensory ability of the plantar aspect of the foot.  It comprises a series of textured 146 
foot plates, each with standardised and quantifiable gratings. The test involves the haptic exploration 147 
of underfoot textured plates in a series of increasingly difficult trials until a roughness discrimination 148 
threshold is reached (i.e. the point at which the participant cannot discriminate between two textures). 149 
The gratings are expressed as spatial intervals (i.e. the distance between measured in micrometres 150 
(µm) (1µm = 1/1000 millimetre (mm)).  The larger the spatial interval, the rougher the surface is 151 
perceived to be up to a point of between 3000 -3500µm.25 This provides a roughness discrimination 152 
threshold in micrometres (µm). 153 
These discrimination tests are undertaken with the participant in standing to reflect, as near as 154 
possible, “real life” foot-ground sensorimotor interactions. Upper limb support was provided for 155 
safety and to aid participants with balance/weight transfer. Participants were requested to look straight 156 
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ahead and avoid looking down at their feet during the testing procedure. In each test, a greater 157 
discrimination threshold indicates worse somatosensory ability. 158 
Measures of balance, gait and falls 159 
The Brief Balance Evaluation Systems Test (Brief BESTest)26 is an eight item test, developed 160 
from the original BESTest,27  and assesses six subsystems of static and dynamic balance control: 161 
biomechanical constraints, stability limits/verticality, anticipatory postural responses, postural 162 
responses, sensory orientation, and stability in gait. Administration time is less than 10 minutes, 163 
making it feasible to use in clinical practice, whilst concurrent and convergent validity has been 164 
demonstrated in individuals with Parkinson’s disease.28  165 
The 10 metre Walk Test (10mWT)29 was used to assess gait speed (comfortable walking speed 166 
using a rolling start) and stride length calculated in metres per second and steps per metre 167 
respectively. The 10mWT is recommended for use in assessing gait speed in PD.30  168 
Falls Incidence. Falls data was collected through participant retrospective recall over the 169 
previous three month period. This is recommended as a simple, and effective starting point for 170 
establishing falls history.31 We used a well-accepted definition of falls: ‘an unexpected event in which 171 
the participant comes to rest on the ground, floor, or lower level’32 172 
Fear of falling. Fear of falling was measured using the Falls Efficacy Scale - International 173 
(FES-I)33 a 16-item self-report tool, which measures an individual’s level of concern about falling 174 
during social and physical activities inside and outside the home. Higher scores indicate greater fear 175 
of falling, which is associated with future falls, activity limitations and reduced quality of life in PD.34    176 
Statistical analysis 177 
Statistical analyses were performed using SPSS version 22.0.  Data were summarised using 178 
frequencies and percentages, mean and standard deviation (SD) or median and inter-quartile range 179 
(IQR) as appropriate. Data distribution was assessed for normality using Shapiro-Wilks tests and 180 
assumed normally distributed when p>0.05. Data presented for the GradDT™, StepDT™   and 181 
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FoRDT™ represent discrimination thresholds expressed in the original measurement units. Larger 182 
discrimination thresholds indicate worse sensory function.   183 
Necessary assumptions in reliability testing were accounted for which included stability 184 
between testing sessions of participant sensory function and consistency in the testing situation 185 
(environment, test procedure, medication and time of day). Intra-rater reliability were analysed using 186 
Intra class Correlation Coefficient (ICC2,1) in line with the Guidelines for Reporting Reliability and 187 
Agreement Studies (GRRAS).35  Standard error of measurement (SEM) provided an indication of the 188 
score likely due to measurement error.  Coefficient of repeatability (CoR), a measure of absolute 189 
reliability provided a score change (in the original measurement scale), which included random and 190 
measurement error and so any score above CoR reflects true/real change or smallest real difference.36 191 
It was calculated by multiplying the SEM by 2.77 (√ 2 x 1.96).36 192 
Sensory performance of the lower limbs of people with PD and matched healthy controls 193 
allowed for an evaluation of known group validity. A Mann Whitney U test was used to determine 194 
statistical significance between the groups (p<0.05) as data for each sensory measures was not 195 
normally distributed. Effect size (Cohen’s d) was calculated to show the size of any difference, using 196 
a standardised formula37 and interpreted using Cohen’s38 criteria of 0.1 = small effect, 0.3 =medium 197 
effect and 0.5 =large effect. Convergent validity was evaluated by comparing our novel tests with the 198 
EmNSA with the magnitude of the relationship determined using a Spearman’s rank order correlation.   199 
The magnitude of the relationship between our novel measures of somatosensation and measures of 200 
gait, falls and dynamic balance were evaluated using Spearman and Pearson correlational analysis 201 
where appropriate. Strength of correlations were interpreted using the classification where ≤0.29 = 202 
weak, 0.30- 0.49 = moderate and, ≥0.50 = strong.38   203 
Results 204 
Demographic and clinical characteristics: Fifty-four people, 27 people with PD (mean age 71 205 
+/- 5.8 years, male/female = 19/8, and 27 age matched healthy adults (mean age 70 +/- 7 years, 206 
male/female = 17/10) were recruited. Parkinson’s participants had a mean Movement Disorder 207 
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Society - Unified Parkinson’s Disease Rating Scale motor score (MDS-UPDRS III) of 30.11 +/- 14.7 208 
(Table 1)   209 
Intra-rater reliability: Test-retest reliability of the novel measures is shown in table 2. Good 210 
to excellent mean ICC values were demonstrated in each novel test (ICC =0.72-0.92). Wide 95% 211 
confidence intervals in the foot roughness and step height discrimination tests were demonstrated.  212 
Coefficient of repeatability scores (i.e. random and measurement error) in the GradDT™ represented 213 
37% of baseline score, 68% in the FoRDT™ and 55% in the StepDT™. Higher scores represent 214 
larger random and measurement error. Known Groups Validity: People with PD performed worse on 215 
sensory measures compared to healthy controls, indicating worse somatosensory function in the lower 216 
limbs (Table 3).  A Mann Whitney U test revealed significant differences in gradient discrimination 217 
thresholds of PD (median=2.5°) and healthy controls (median =1.4°, U=179, z=-3.86, p<0.001, 218 
r=.52). Foot roughness discrimination thresholds in PD (median 400µm) whilst higher than healthy 219 
controls (median =300µm) were not significantly different (U=353, z=-1.207, p=0.22, r=0.16). Step 220 
height discrimination thresholds were significantly different between PD (median =1.8cm) and 221 
healthy controls (median=1.2cm, U=209, z=-3.478, p=0.001, r=0.47). EmNSA tactile sensation scores 222 
in PD (median =64) were not significantly different from healthy controls (median =62, U=399, Z=-223 
0.533,p=0.59, r= 0.07). EmNSA proprioception scores were also not significantly different between 224 
people with PD (median =16) and healthy controls (median =16, U=392, z=-1.013, p=0.31, r=0.13). 225 
Using the EmNSA sensory measure, 55% of people with PD (n=15/27) scored the maximum 226 
score (64/64) on tactile sensation component (range 49-64). In the proprioception component of the 227 
EmNSA, 81% (n=22/27) of people with PD scored maximally (i.e. 16/16); comparable to healthy 228 
control performance (88%, n=24/27).  In the novel measures, no single person with PD nor control 229 
participant scored the maximum or minimum.  230 
Convergent validity: To evaluate convergent validity, strength of associations between the 231 
novel measures and an existing measure of tactile and proprioceptive sensation, the EmNSA were 232 
evaluated (table 4).  The Foot Roughness discrimination test (FoRDT) showed moderate and 233 
significant inverse correlation (r=-0.45, p<0.05) with the tactile component of the EmNSA. As tactile 234 
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discrimination thresholds increased, scores on the EmNSA fell, indicating worse tactile sensation.  No 235 
other significant correlations were demonstrated between our novel measures and the tactile or 236 
proprioception components of the EmNSA (r=0.11-0.28, p>0.05).  237 
Associations between novel measures and balance, gait and falls: Gradient discrimination as 238 
measured with the GradDT™ showed the strongest correlations with functional measures of falls and 239 
balance (table 5).  A significant and strong inverse relationship between the GradDT™ and 240 
BriefBESTest (r=-0,63, p<0.01) indicates that those with higher gradient discrimination thresholds 241 
(i.e worse position sense) had lower scores on the BriefBESTest (i.e worse balance performance). The 242 
GradDT™ also showed a strong positive correlation with falls incidence and moderate correlation 243 
with the Falls Efficacy Scale – International (FES-I), indicating that those with worse gradient 244 
discriminative ability reported more falls (r=0.55, p<0.01) and had greater concerns about falling 245 
(r=0.44, p<0.05). No significant associations between any sensory measure and spatial or temporal 246 
aspects of gait were demonstrated. 247 
Discussion 248 
In this study, we evaluated three novel tests of lower limb somatosensory function in a cohort 249 
of people with PD and healthy age matched control participants.  The sensory-perceptual ability to 250 
discriminate surface gradient or slope was assessed during full weight-bearing using the GradDT™. 251 
Discrimination of step height using lower limb position sense was assessed with the StepDT™, and 252 
the ability to discriminate underfoot surface roughness was evaluated using the FoRDT™. Our study 253 
results provide preliminary evidence to support the reliability and validity of these tests in people with 254 
PD, and demonstrate people with PD to have impaired lower limb somatosensory discrimination. 255 
Moreover, these deficits are associated with worse static and dynamic balance, greater falls incidence 256 
and fear of falling. 257 
Our novel measures target key sensorimotor functions related to stance and stepping and use a 258 
robust psychophysical testing approach to establish somatosensory discrimination thresholds, i.e. the 259 
ability to discriminate the spatial qualities (roughness/gradient/step height) of a stimulus. In contrast 260 
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to the more traditional, manual method of assessing lower limb movement detection and direction (i.e. 261 
the proprioceptive component of the EmNSA), our weight-bearing tests of gradient discrimination 262 
(GradDT™) and step height discrimination (StepDT™) highlighted increased somatosensory 263 
discrimination thresholds in people with PD and found these deficits had moderate to strong 264 
significant correlations with balance, reported falls and concern about falling. In line with our 265 
findings, elevated somatosensory discrimination thresholds to temporal stimuli (STDT), that is, the 266 
shortest time interval required for two tactile stimuli to be perceived as separate, have also been found 267 
in people with PD compared to healthy controls.  Elevated discrimination thresholds at the finger and 268 
face39 and toe40 have been identified in PD, and have mostly been observed to be correlated with 269 
movement performance41; our findings lend further support to the presence of somatosensory 270 
dysfunction in people with PD, and its impact on movement performance, movement function and 271 
sensorimotor integration.   272 
Movement and balance are reliant on a complex interaction between sensory and motor 273 
systems42 whilst the central processing of sensory information ensures the production of a motor plan 274 
for task execution that is appropriate to the sensory environment.43 In PD it is postulated that deficits 275 
of central processing of somatosensory information, rather than pathology of the peripheral nervous 276 
system result in altered integration of sensory and motor information4,44 and in particular 277 
proprioceptive information45. An important function of the dorsal striatum within the basal ganglia 278 
(one of the main channels of information processing) is suggested to be the treatment of sensory and 279 
motor information coming from the sensorimotor cortex and integrating visual and proprioceptive 280 
information onto the motor command.46  Using methods which target the integrity of these central 281 
processes and the perceptual constructs they sustain may be better achieved by sensory measures 282 
which assess discriminative perception rather than simple touch or movement detection. Our data 283 
suggest our lower limb novel measures may be better suited to capturing the complexity of 284 
somatosensory dysfunction in PD compared to an existing, widely used clinical measure.  285 
That our novel measures of gradient discrimination and step height discrimination were only 286 
weakly correlated with the proprioceptive component of the EmNSA suggests they may be measuring 287 
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different constructs. This may, at least in part, be accounted for by the fact that the EmNSA assessed 288 
proprioception with the participant in supine/sitting, in contrast to our novel measures which assessed 289 
position sense with the participant standing in full weight-bearing. Sense of position and sense of 290 
movement have also been shown by others to only weakly correlate47 which may further help to 291 
explain this finding.   292 
The presence of plantar tactile sensory dysfunction in people with PD was not evident in this 293 
study as neither tactile scores of the EmNSA nor discrimination thresholds to roughness perception 294 
(FoRDT™) were significantly different from healthy controls. Furthermore, tactile plantar sensation 295 
as measured by the FoRDT™ did not significantly correlate with our mobility outcomes.  Current 296 
evidence pertaining to the presence of plantar tactile sensory deficits in people with PD is 297 
equivocal4,48 with contrasting results explained by variations in study sample characteristics such as 298 
disease stage, symptom severity and sensory assessment methods.  That most participants in our study 299 
were in the early-moderate stages of PD (mean Hoehn & Yahr stage =2.3; time since diagnosis =5.7 300 
years) suggests that reported plantar tactile sensory changes may not occur in early PD. We also 301 
recognise the complex and multifactorial nature of balance impairment in PD and the involvement of 302 
several ‘systems’ in addition to the somatosensory system27 and so factors other than plantar tactile 303 
deficits may also contribute to balance deficits. Nonetheless, that significant deficits of plantar 304 
sensation were not evident in our sample, yet proprioceptive deficits were, supports the potential for 305 
interventions targeting the plantar aspect of the foot to enhance lower limb position 306 
sense/proprioception.  307 
Our study supports that diminished position sense awareness of the lower limbs may also 308 
contribute to an increased risk of falls.  The strong and significant correlations between lower limb 309 
position sense as measured with the GradDT™ and StepDT™ falls incidence and falls confidence 310 
indicates worse position sense awareness of the lower limb is significantly associated with more falls 311 
and greater fear of falling. This is in line with the findings of others who have found greater error 312 
performance and variability in judging obstacle heights when relying on lower limb proprioception10 313 
which may contribute to an increased risk of trips; and that people with PD who fall have significantly 314 
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worse lower limb proprioception, compared to those who don’t fall.7 The link between falls and lower 315 
limb proprioceptive impairment has also been identified in other clinical populations.16,49 316 
Neither temporal nor spatial aspects of gait, as measured by straight line gait speed and 317 
number of steps, respectively, were significantly associated with lower limb somatosensory function. 318 
Similar findings have been identified in previous studies of healthy and neurological populations16,50 319 
and explained by the increased use or sensory weighting of visual information during walking tasks, 320 
which may reduce the need for accurate somatosensory information from the lower limbs. In essence, 321 
‘simple’ straight line gait tasks may be completed using minimal somatosensory information and 322 
processing as visual feedback compensates.  EEG studies,51,52 demonstrate that more complex gait 323 
tasks, such as uphill walking and narrow beam walking result in increased activation within 324 
somatosensory cortical regions compared with simple straight line gait tasks on the flat, suggesting a 325 
greater role for somatosensory information during more complex walking tasks.  326 
Intra-rater reliability was excellent in the GradDT™ although wide reliability confidence 327 
intervals and substantial coefficient of repeatability scores for the FoRDT™ and StepDT™ highlight 328 
the occurrence of random and/or measurement error. Reliability is an issue in sensory assessments 329 
particularly in neurological populations12 and whilst we attempted to control for random and 330 
measurement error, we postulate that the effect of fluctuations in participant energy levels, fatigue and 331 
possibly attention, may account for this. The clinical implication is that somatosensory function in 332 
people with PD, as with other symptoms, may not be established through one-off assessments, but 333 
should be assessed on several occasions in order to gain a true picture.  Nonetheless, our novel 334 
measures have demonstrated to have distinct advantages over existing measures of lower limb 335 
sensation in that they employ an interval level of measurement and show, in this sample, no floor or 336 
ceiling effects. The SEM and CoR data provide an indication of random and measurement error which 337 
enables interpretation of the true change in scores.  Because the CoR is quantified in the same units as 338 
the assessment tool, it lends itself for easy clinical interpretation, and can be used to guide decision 339 
making. A change in discriminative ability in the gradient test of +/- 0.85° for example, would 340 
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indicate change beyond random and measurement error; critical for the monitoring of disease 341 
progression and the evaluation of interventions. 342 
 This study has several limitations. The testing of discriminative ability places demands on 343 
cognitive functions such as attention and working memory; functions which are known to be affected 344 
in PD53 and may be further confounded by fatigue and/or motivation.54 Formal assessment of fatigue 345 
or motivation was not undertaken in this study, so the extent to which it influenced test outcome 346 
cannot be determined. We also did not run separate analysis on the effect of lower limb tremor or 347 
dyskinesia on somatosensory performance so cannot rule out the impact of these symptoms as our 348 
novel tests were designed to reflect ‘real life’ foot-ground sensorimotor interactions during weight-349 
bearing.  A further limitation relates to the generalisability of our findings. Our sample was comprised 350 
of people in the mild to moderate stages of PD who were tested during the ‘ON’ phase, and so the 351 
results may not generalise to those in the more advanced stages of the disease, nor reflect 352 
somatosensory function during the ‘OFF’ phase.  353 
Conclusion 354 
To develop targeted and appropriate rehabilitation interventions for people with PD, the 355 
recognition that lower limb sensation informs movement and balance function is critical.  Key to this 356 
is the availability and use of appropriate, clinically feasible and psychometrically robust assessment 357 
tools. The development and use of sensory measures which are more closely aligned with the complex 358 
sensory-motor function of the lower limb, such as the novel measures evaluated in this article, may 359 
enhance understanding in this relatively understudied area of PD. It is hoped that this study provides 360 
further insight, and generates discussion into recognising the importance of evaluating somatosensory 361 
ability, its relevance to movement, and its rehabilitation in this clinical population.   362 
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Table 1. PD and control participant demographic and clinical characteristics  
        
  PD  Control  
 Characteristics (n=27) (n=27)  
       
Age, years, mean (SD) 71 (5.8) 70 (7.0)  
       
Gender n (%)      
Male 19 (70.4) 17 (62.9) 
 
Female 8 (29.6) 10 (37.1) 
       
Time since diagnosis, years mean 
(SD) 
 
5.7 (4.9)  -  
    
Hoehn & Yahr stage, n (%)    
1 3 (11.1) -  
2 14 (51.9)  -   
3 9 (33.3) -  
4 1 (3.7) -  
       
MDS-UPDRS Score, mean (SD)  30.1 (14.7)     
       
Number of falls reported n (%)      
0 12 (44.4) 20 (74)  
1 3 (11.1) 4 (15)  
2 2 (7.4) 3 (11)  
3 4 (14.8) 0  
>4 6 (22.3) 0  
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 540 
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Table 2. Intra-rater reliability of novel sensory measures 541 
 
 Intra-rater Reliability (Parkinson’s n=27) 
 
Measure 
Test 1 (T1) Test 2 (T2) 
Mean           
(T1 
&T2) 
SEM   ICC(2,1) (95% CI) CoR 
 
GradDT™ threshold 
degrees (°) mean (SD) 
2.4 (1.2 ) 2.2 (1.0) 2.3 (1.1) 0.31  0.92 (0.82-0.96)* 
 
0.85 
 
FoRDT™  threshold 
µm, mean (SD) 
480 (240) 520 (210) 
500 
(235) 
124  0.72 (0.38-0.87)* 
 
 
340 
 
StepDT™ threshold  
cm mean (SD) 
1.8 (0.9) 1.9 (0.7) 1.8 (0.7) 0.36  0.73 (0.40-0.88)* 1.0 
        
Abbreviations: GradDT, Gradient Discrimination Test; StepDT, Step-height Discrimination Test;   
FoRDT, Foot Roughness Discrimination Test; cm, centimetres; SD, Standard Deviation; SEM, Standard 
error of measurement;  ICC(2,1) Intraclass Correlation Coefficient model 2,1; CI, Confidence Interval; 
CoR, Coefficient of Repeatability  
*P<0.001 
 
 542 
 543 
 544 
 545 
 546 
 547 
 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
22 
 
 557 
Table 3. Comparison of sensory performance between people with Parkinson’s disease (PD) and 558 
healthy control group 559 
Sensory Measure PD  
(n=27) 
Control  
(N=27) 
p Effect Size d  
 
GradDT™ threshold 
    
degrees (°)  
Median (IQR, range) 
 
2.5° (1.75°, 5.5°) 
 
1.4° (1.1°, 2.5°) 
 
<0.001 
 
0.52 
     
     
FoRDT™ threshold µm 
Median (IQR, range) 
 
400 (400, 900) 
 
300 (325, 850) 
 
0.22 
 
0.16 
     
     
StepDT™ threshold cm     
Median (IQR, range) 1.8 (1.2, 3.0) 1.2 (0.6, 1.8) 0.001 0.47 
     
EmNSA score, median (IQR, 
range 
    
Tactile Sensation (0-64) 64 (7,15) 62 (4,13) 0.59 0.07 
Proprioception score (0-16) 16 (0, 2) 16 (0,2) 0.31 0.13 
     
Abbreviations: GradDT, Gradient Discrimination Test; StepDT, Step-height Discrimination Test;  FoRDT, 
Foot Roughness Discrimination Test; EmNSA, Erasmus modified version of Nottingham Sensory 
Assessment; cm, centimetres; SD, Standard Deviation; µm, micrometres; d Cohen’s d. 
 560 
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 573 
Table 4. Spearman rank order correlation coefficients between novel measures and Erasmus MC 574 
modified Nottingham Sensory Assessment 575 
 EmNSA Sensory Modality 
 
Sensory Measure Tactile Score Proprioception Score 
   
GradDT™ -0.25 -0.21 
   
StepDT™ -0.29 -0.28 
   
FoRDT™ -0.45* -0.11 
   
*p<0.05 
Abbreviations: EmNSA, Erasmus MC modified Nottingham Sensory Assessment; GradDT™, 
Gradient Discrimination Test; StepDT™, Step Height Discrimination Test; FoRDT™, Foot 
Roughness Discrimination Test 
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 591 
Table 5. Spearman rank order correlation coefficients between sensory measures and functional 592 
mobility measures 593 
   
            
  
Falls 
Incidence 
Falls Efficacy 
Scale -I  
Brief 
BESTest 
Gait 
Speed m/s  Step length  
Sensory Measure           
            
GradDT 0.55** 0.44*  - 0.63** 0.20 0.06 
            
StepDT 0.24 0.1  - 0.54** 0.12 0.09 
            
FoRDT 0.03 0.15 -0.11 -0.17 0.05 
            
EmNSA (Tactile) -0.21 -0.37 0.17 0.03 0.02 
            
EmNSA 
(Proprioception) 0.15 -0.37 -0.31 0.15 0.17 
            
            
*p<0.05; **P,0.01; Abbreviations: GradDT, Gradient Discrimnation Test; StepDT, Step height 
discrimination test; FoRDT, foot roughness discrimination test; EmNSA, Erasmus MC modified 
Nottingham Sensory Assessment; FES-I, Falls Efficacy Scale – International; BriefBESTest, 
Brief version of Balance Evaluations Systems Test;       
 594 
